L Montus Tablet contains a combination of Levocetirizine 5mg and Montelukast 10mg, formulated to provide effective relief from allergic conditions and respiratory disorders. Levocetirizine is a second-generation antihistamine that selectively inhibits peripheral H1 receptors, thereby reducing symptoms such as sneezing, nasal congestion, rhinorrhea, and itching associated with allergic rhinitis and chronic urticaria. Montelukast is a leukotriene receptor antagonist that blocks the action of leukotrienes, inflammatory mediators involved in bronchoconstriction, mucus production, and airway edema, making it beneficial in the management of asthma and allergic rhinitis. The combination of these two agents offers a dual mechanism of action, targeting both histamine and leukotriene pathways, resulting in enhanced symptom control. L Montus Tablet is indicated for the treatment of seasonal and perennial allergic rhinitis, chronic idiopathic urticaria, and as an adjunct therapy in asthma management to improve respiratory function and reduce exacerbations. It is generally well-tolerated, with a low incidence of side effects such as headache, fatigue, and gastrointestinal discomfort. Patients should use this medication under medical supervision, adhering to prescribed dosages to ensure optimal therapeutic outcomes and minimize potential adverse reactions.